I Hate Dialysis Message Board
Welcome, Guest. Please login or register.
April 26, 2024, 07:51:23 AM

Login with username, password and session length
Search:     Advanced search
532606 Posts in 33561 Topics by 12678 Members
Latest Member: astrobridge
* Home Help Search Login Register
+  I Hate Dialysis Message Board
|-+  Dialysis Discussion
| |-+  Dialysis: News Articles
| | |-+  To calcify or to calcify less
0 Members and 1 Guest are viewing this topic. « previous next »
Pages: [1] Go Down Print
Author Topic: To calcify or to calcify less  (Read 2589 times)
cassandra
Elite Member
*****
Offline Offline

Gender: Female
Posts: 4974


When all else fails run in circles, shout loudly

« on: August 29, 2016, 08:32:52 AM »

Authors
CAROLYN L VAN EPS,
JANINE K JEFFRIES,
JOHN A ANDERSON,
PATRICK T BERGIN,
DAVID W JOHNSON,
SCOTT B CAMPBELL,
SALLY M CARPENTER,
NICOLE M ISBEL,
DAVID W MUDGE,
CARMEL M HAWLEY
First published: 6 February 2007Full publication history
DOI: 10.1111/j.1440-1797.2006.00712.xView/save citation
Cited by: 19 articlesCitation tools
Associate Professor Carmel M Hawley, Department of Nephrology, Level 2, ARTS Building, Princess Alexandra Hospital, Ipswich Road, Woolloongabba, Qld 4102, Australia. Email: carmel_hawley@health.qld.gov.au
SUMMARY:

Background:  Poor control of bone mineral metabolism (BMM) is associated with renal osteodystrophy and mortality in dialysis-dependent patients. The authors explored the efficacy of alternate nightly home haemodialysis (ANHHD) in controlling BMM parameters and its effects on bone mineral density and histomorphometry.

Methods:  In this prospective observational study, 26 patients on home haemodialysis (3–5 h, 3.5–4 sessions weekly) were converted to ANHHD (6–9 h, 3.5–4 sessions weekly). Biochemical parameters of BMM at baseline, 6 and 12 months, radiological parameters at baseline and 12 months and bone histomorphometry at 12 months are described.

Results:  Pre-dialysis serum phosphate fell from 2.13 ± 0.65 to 1.38 ± 0.35 mmol/L; P < 0.0001. No binders were required in 77.2% compared with 7.7% at baseline. Calcium-phosphate product fell from 5.28 ± 1.64 to 3.42 ± 0.88 mmol2/L2; P < 0.0001 and parathyroid hormone (PTH) from 301 (110–471) to 127 (47–240) ng/L; P = 0.01. Bone mineral density remained stable. Vascular and ectopic calcification improved or stabilized in 87.5%. Bone histomorphometry at 12 months showed high, normal and low bone turnover in 10, 3 and 4 patients, respectively, with 6/17 patients having abnormal mineralization.

Conclusion:  Alternate nightly home haemodialysis effectively manages biochemical parameters of BMM. Patients with very high PTH at baseline (>1000 ng/L) did not significantly improve parathyroid hormone status. Abnormal bone turnover and mineralization were present in a significant proportion of patients at 12 months but low turnover was uncommon. Vascular calcification was stabilized or improved in the majority. ANHHD compares favourably with every night and short daily therapy in relation to BMM management and may offer lifestyle advantages for patients.


Logged

I started out with nothing and I still have most of it left

1983 high proteinloss in urine, chemo, stroke,coma, dialysis
1984 double nephrectomy
1985 transplant from dad
1998 lost dads kidney, start PD
2003 peritineum burst, back to hemo
2012 start Nxstage home hemo
2020 start Gambro AK96

       still on waitinglist, still ok I think
Pages: [1] Go Up Print 
« previous next »
 

Powered by MySQL Powered by PHP SMF 2.0.17 | SMF © 2019, Simple Machines | Terms and Policies Valid XHTML 1.0! Valid CSS!